​

Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary


Amneal Pharmaceuticals is owned by 49.93% institutional investors, 52.18% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.42% of AMRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 3.19% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals49.93%52.18%-2.11%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.69%14.20%48.11%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de26.88M8.42%$541.31M
Vanguard group17.91M5.70%$225.64M
Vanguard portfolio management12.37M3.87%$249.04M
Tpg gp a12.33M3.75%$213.41M
Blackrock11.28M3.67%$71.64M
Rubric capital management lp10.17M3.09%$176.02M
Vanguard capital management7.99M2.50%$160.87M
State street7.47M2.34%$150.47M
Invesco5.97M1.87%$120.14M
Dimensional fund advisors lp5.82M1.82%$117.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Westshore wealth1.37M7.34%$23.65M
Tpg gp a12.33M4.27%$213.41M
Quartz partners433.07K2.64%$8.72M
Tucker asset management511.06K2.54%$10.29M
Signature wealth management partners232.43K2.00%$4.68M
Phocas financial819.48K1.97%$14.19M
Blackbarn capital partners lp1.30M1.90%$22.50M
Rubric capital management lp10.17M1.61%$176.02M
Rpg family wealth advisory401.49K1.44%$8.09M
Nantahala capital management2.12M1.35%$42.61M

Top Buyers

HolderShares% AssetsChange
Invesco5.97M0.01%2.46M
Blackrock11.28M0.00%2.12M
Congress asset management co /ma1.52M0.20%741.58K
Citadel advisors1.12M0.00%541.30K
Allspring global investments3.83M0.12%536.05K

Top Sellers

HolderShares% AssetsChange
Sixth street partners management company---2.15M
Fosun---1.72M
Woodline partners lp---1.50M
Hennessy advisors---1.50M
Penn capital management company---1.18M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp272.00K0.01%272.00K$4.71M
Danske bank271.29K0.01%271.29K$5.46M
Signature wealth management partners232.43K2.00%232.43K$4.68M
Norges bank219.40K0.00%219.40K$3.80M
Wilshire advisors187.36K0.01%187.36K$3.77M

Sold Out

HolderChange
Twin peaks wealth advisors-3.00
Newedge advisors-5.00
Plante moran financial advisors-6.00
Global financial private client-12.00
Vermillion wealth management-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026307-3.46%164,231,0132.72%491.92%182-7.14%858.97%
Mar 31, 202631412.14%158,512,7392.52%502.09%19526.62%77-7.23%
Dec 31, 2025209-16.40%121,259,006-19.77%381.66%107-19.55%65-13.33%
Sep 30, 20252431.25%148,491,3234.94%472.33%131-5.76%7325.86%
Jun 30, 2025235-0.42%141,337,0205.14%452.41%138-2.13%565.66%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF11.11M3.19%5.69K
Columbia Strategic Income A6.26M1.80%1.80M
Vanguard Morn Total Stk Mkt Idx Investor5.56M1.74%4.76K
Vanguard Total Stock Mkt Idx Inv5.56M1.74%4.76K
Vanguard MStar Total Stk Mkt Idx Invest5.60M1.61%24.90K
Vanguard US Total Market Shares ETF4.36M1.39%-
iShares Russell 2000 ETF3.94M1.13%-
Vanguard Small Cap Index3.92M1.13%-110.98K
Vanguard Morn Small Cap Value Index2.56M0.80%-8.15K
Vanguard Small Cap Value Index Inv2.56M0.80%-8.15K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2026Kiely John-Sell$882.00K
Aug 12, 2026Shah Nikita Executive Vice PresidentSell$2.56M
Aug 12, 2026Daly Jason B. EVP, Chief Legal OfficerSell$3.65M
Aug 11, 2026Daly Jason B. EVP, Chief Legal OfficerSell$117.05K
May 11, 2026Autor Deborah M.-Sell$450.56K

Insider Transactions Trends


DateBuySell
2026 Q3-4
2026 Q2-1
2026 Q1--
2025 Q4-2
2025 Q3-11

AMRX Ownership FAQ


Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 49.93%, followed by 52.18% insiders and -2.11% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.69%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (26.88M shares, 8.42%), Vanguard group (17.91M shares, 5.70%), and Vanguard portfolio management (12.37M shares, 3.87%). Together, they hold 17.99% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Westshore wealth is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.34% of its assets in 1.37M Amneal Pharmaceuticals shares, valued at 23.65M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amneal Pharmaceuticals shares, with 3.19% of its total shares outstanding invested in 11.11M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools